On May 22, 2023, Cline Scientific AB (the "Company") received observation status with reference to material adverse uncertainty in respect of the issuer's financial position. On August 2, 2023, the Company issued a press release with information on the outcome of a rights issue raising approximately MSEK 6.1 before issue costs. With reference to the above, Nasdaq Stockholm AB decides that the observation status for the shares in Cline Scientific AB (CLINE B, ISIN code SE0006758231, order book ID 226724) shall be removed. For further information about this exchange notice please contact Enforcement & Investigations, telephone +46 8 405 70 50.